Long-term follow-up of a pediatric regimen for AYA with Ph-negative ALL: 10-Year survival of CALGB 10403 (Alliance)

Authors

• Wellington F Silva, University of Sao Paulo
• Geoffrey L Uy, Washington University School of Medicine in St. Louis
• et al.

Journal

Blood Advances

Publication Date

8-25-2026

Volume

10

Issue

16

First Page

5487

Last Page

5491

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2026019616

Rights and Permissions

Silva WF, Yin J, Liedtke M, Claxton DF, Fulton N, Giri S, Malnassy G, Mrózek K, Paietta E, Mullighan CG, Galinsky I, Bogart JA, Grecula JC, Kennedy L, Larson RA, Stone RM, Uy GL, Luger SM, Advani AS, Stock W. Long-term follow-up of a pediatric regimen for AYA with Ph-negative ALL: 10-year survival of CALGB 10403 (alliance). Blood Adv. 2026 Aug 25;10(16):5487-5491. doi: 10.1182/bloodadvances.2026019616. © 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Silva, Wellington F; Uy, Geoffrey L; and et al., "Long-term follow-up of a pediatric regimen for AYA with Ph-negative ALL: 10-Year survival of CALGB 10403 (Alliance)." Blood Advances. 10, 16. 5487 - 5491. (2026).
https://digitalcommons.wustl.edu/oa_4/7460

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.